Interleukin-15 as a potential costimulatory cytokine in CD154 gene therapy of chronic lymphocytic leukemia

Blood. 2002 Jan 15;99(2):722-3. doi: 10.1182/blood.v99.2.722.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Apoptosis
  • CD40 Antigens / immunology
  • CD40 Ligand / genetics
  • CD40 Ligand / physiology*
  • Fas Ligand Protein
  • Genetic Therapy*
  • Humans
  • Interleukin-15 / genetics
  • Interleukin-15 / physiology*
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
  • Lymphocyte Activation
  • Membrane Glycoproteins / physiology
  • Neoplastic Stem Cells / transplantation
  • Signal Transduction
  • T-Lymphocyte Subsets / immunology
  • Th1 Cells / immunology
  • fas Receptor / physiology

Substances

  • CD40 Antigens
  • FASLG protein, human
  • Fas Ligand Protein
  • Interleukin-15
  • Membrane Glycoproteins
  • fas Receptor
  • CD40 Ligand